Valsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5813-77.
Published December 19, 2018 · Recall initiated: December 4, 2018
Summary
FDA records drug Class II recall D-0325-2019, published December 19, 2018 and initiated December 4, 2018. Recalling firm: Mylan Laboratories Limited, (Nashik FDF); Status: Ongoing; Reported quantity: 119,761 HDPE bottles; Lot: Lot Numbers: 3065445, 3074880, 3074883, 3086688, 3086689, 3086710. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
What to do
Voluntary: Firm initiated · Press Release
Get an email if VALSARTAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VALSARTAN
- Manufacturer
- Mylan Laboratories Limited, (Nashik FDF)
- Distributor
- Product was distributed throughout the United States to several major distributors, including Puerto Rico.
- UPC
- 0303785815778
- Lot
- Lot Numbers: 3065445, 3074880, 3074883, 3086688, 3086689, 3086710
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAValsartan Tablets USP 40 mg, 30 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJMarch 27, 2019
- FDAValsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton,January 23, 2019
- FDAValsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAAmlodipine and Valsartan Tablets, USP 5/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for:December 19, 2018
- FDAValsartan Tablets, USP 160 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
Questions about this recall
Was Valsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5813-77. recalled?
Yes. FDA published recall D-0325-2019 on December 19, 2018. Reported hazard: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VALSARTAN. UPC: 0303785815778.